Collin et al. [16,17] found that two folate pathway polymorphisms (MTR 2756A > G and SHMT1 1420C > T) and circulating concentrations of vitamin B12 were associated with an increased risk of prostate cancer. This evidence concerns the gene MTR and prostate carcinoma.